A Phase 3, Randomized, Triple-Blind, Paralle-Group, Long-Term, Placebo-Controlled, Multicenter Study to Examine the Effect on Glucose Control (HbA1c) of AC2993 Given Two Times a Day in Subjects with Type 2 Diabetes Mellitus Treated with Metformin Alone